New stroke drug aims to lock in recovery after clot removal
NCT ID NCT07335107
Summary
This study is testing if adding a blood-thinning drug called tirofiban after emergency stroke treatment helps patients recover better. It will involve 564 adults in China who have just had a major stroke caused by a blocked artery and have already received clot-busting medicine and a procedure to remove the clot. The main goal is to see if more people can return to independent living 90 days after their stroke.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100070, China
Conditions
Explore the condition pages connected to this study.